Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus

Virologica Sinica

Volumn 33, Issue 5, 2018, Pages 453-455

  Lan, Jiaming ^a,b   Deng, Yao ^a   Song, Jingdong ^a   Huang, Baoying ^a   Wang, Wenling ^a   Tan, Wenjie ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; VIRUS LIKE PARTICLE VACCINE; CORONAVIRUS SPIKE GLYCOPROTEIN; VIRUS ANTIBODY; VIRUS VACCINE;

ANTIBODY TITER; CHIMERA; FATALITY; HUMAN; HUMORAL IMMUNITY; LETTER; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MORBIDITY; MOUSE; NONHUMAN; VACCINE IMMUNOGENICITY; VIRION; VIRUS LIKE AGENT; VIRUS MORPHOLOGY; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CORONAVIRUS INFECTION; FEMALE; IMMUNOLOGY; ISOLATION AND PURIFICATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CORONAVIRUS INFECTIONS; FEMALE; IMMUNITY, HUMORAL; IMMUNOGENICITY, VACCINE; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; SPIKE GLYCOPROTEIN, CORONAVIRUS; VACCINES, VIRUS-LIKE PARTICLE; VIRAL VACCINES;

EID: 85055973361     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-018-0064-8     Document Type: Letter

References (6)

1. Deng Y, Lan J, Bao L, Huang B, Ye F, Chen Y, Yao Y, Wang W, Qin C, Tan W (2018) Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus. Emerg Microbes Infect 7:60
2. Lan J, Deng Y, Chen H, Lu G, Wang W, Guo X, Lu Z, Gao GF, Tan W (2014) Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen. PLoS ONE 9:e112602
3. Liu YV, Massare MJ, Barnard DL, Kort T, Nathan M, Wang L, Smith G (2011) Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV. Vaccine 29:6606–6613
4. Okba NM, Raj VS, Haagmans BL (2017) Middle East respiratory syndrome coronavirus vaccines: current status and novel approaches. Curr Opin Virol 23:49–58
5. van Boheemen S, de Graaf M, Lauber C, Bestebroer TM, Raj VS, Zaki AM, Osterhaus AD, Haagmans BL, Gorbalenya AE, Snijder EJ, Fouchier RA (2012) Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio 3:e00473–12
6. Wang C, Zhang X, Gai W, Zhao Y, Wang H, Wang H, Feng N, Chi H, Qiu B, Li N, Wang T, Gao Y, Yang S, Xia X (2017) MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques. Oncotarget 8:12686–12694